Makoto Miyazaki Selected Research

Acute Kidney Injury (Acute Renal Failure)

1/2020	The effect of MEK1/2 inhibitors on cisplatin-induced acute kidney injury (AKI) and cancer growth in mice.
1/2018	IL-33 deficiency slows cancer growth but does not protect against cisplatin-induced AKI in mice with cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Makoto Miyazaki Research Topics

Disease

13	Neoplasms (Cancer) 04/2024 - 02/2003
13	Vascular Calcification 01/2022 - 06/2010
12	Obesity 01/2010 - 02/2003
9	Inflammation (Inflammations) 01/2024 - 02/2008
9	Atherosclerosis 01/2018 - 11/2004
9	Insulin Resistance 01/2011 - 08/2002
8	Chronic Renal Insufficiency 01/2024 - 06/2010
4	Breast Neoplasms (Breast Cancer) 10/2018 - 12/2013
4	Atherosclerotic Plaque (Atheroma) 01/2014 - 07/2010
3	Fibrosis (Cirrhosis) 01/2024 - 08/2014
3	Carcinoma (Carcinomatosis) 08/2022 - 08/2021
3	Dyslipidemias (Dyslipidemia) 07/2022 - 06/2006
3	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2020 - 03/2019
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 12/2013
3	Cardiovascular Diseases (Cardiovascular Disease) 06/2014 - 02/2003
3	Body Weight (Weight, Body) 03/2009 - 12/2003
3	Fatty Liver 02/2009 - 02/2004
3	Hypertriglyceridemia 02/2009 - 11/2002
2	Neoplasm Metastasis (Metastasis) 04/2024 - 01/2023
2	Hypertension (High Blood Pressure) 09/2023 - 07/2022
2	Type 2 Diabetes Mellitus (MODY) 07/2022 - 10/2005
2	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 01/2018
2	Necrosis 01/2020 - 01/2018
2	Acute Kidney Injury (Acute Renal Failure) 01/2020 - 01/2018
2	Kidney Diseases (Kidney Disease) 01/2019 - 10/2016
2	Proteinuria 01/2019 - 05/2012
2	Hypoxia (Hypoxemia) 10/2018 - 01/2017
2	Diabetic Nephropathies (Diabetic Nephropathy) 10/2016 - 05/2012
2	Dehydration (Water Stress) 10/2016 - 08/2014
2	Hyperlipidemias (Hyperlipidemia) 01/2016 - 11/2002
2	Wounds and Injuries (Trauma) 11/2012 - 11/2012
2	Weight Loss (Weight Reduction) 03/2009 - 07/2002
2	Hypoglycemia (Reactive Hypoglycemia) 12/2007 - 09/2004
2	Hypercholesterolemia 12/2006 - 05/2005
2	Hyperinsulinism (Hyperinsulinemia) 07/2006 - 02/2004
2	Heart Failure 12/2004 - 12/2003
1	Polycystic Kidney Diseases (Polycystic Kidney Disease) 04/2024
1	Gout 04/2024
1	Cysts 04/2024
1	Chronic Kidney Diseases of Uncertain Etiology 01/2024

Drug/Important Bio-Agent (IBA)

13	Stearoyl-CoA DesaturaseIBA 09/2020 - 11/2002
8	Apolipoproteins E (ApoE)IBA 01/2016 - 02/2009
7	LipidsIBA 07/2022 - 03/2005
7	Bile Acids and Salts (Bile Acids)IBA 01/2022 - 12/2006
6	Fatty Acids (Saturated Fatty Acids)IBA 09/2020 - 06/2008
6	LeptinIBA 08/2010 - 07/2002
6	stearoyl-coenzyme A (stearoyl-CoA)IBA 01/2010 - 07/2002
5	EnzymesIBA 05/2020 - 03/2004
5	Proteins (Proteins, Gene)FDA Link 01/2019 - 06/2014
5	CholesterolIBA 01/2016 - 12/2011
4	Glucose (Dextrose)FDA LinkGeneric 07/2022 - 09/2004
4	Deoxycholic Acid (Sodium Deoxycholate)IBA 01/2022 - 01/2018
4	Monounsaturated Fatty AcidsIBA 09/2020 - 02/2003
4	Activating Transcription Factor 4IBA 11/2018 - 08/2012
4	Lipoproteins (Lipoprotein)IBA 01/2018 - 12/2006
4	Triglycerides (Triacylglycerol)IBA 08/2010 - 11/2002
4	Oleic Acid (Oleate)IBA 01/2010 - 09/2004
3	CytokinesIBA 04/2024 - 02/2008
3	HDL CholesterolIBA 09/2023 - 09/2006
3	Phosphotransferases (Kinase)IBA 08/2022 - 09/2013
3	suvorexantIBA 01/2020 - 03/2019
3	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 11/2012
3	LDL Receptors (LDL Receptor)IBA 01/2018 - 12/2011
3	StearatesIBA 08/2012 - 01/2007
3	Insulin (Novolin)FDA Link 01/2011 - 07/2006
3	CarbohydratesIBA 02/2009 - 12/2006
2	VaccinesIBA 11/2021 - 01/2018
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 08/2021 - 01/2018
2	Protein Isoforms (Isoforms)IBA 01/2019 - 08/2002
2	AlbuminsIBA 01/2019 - 10/2018
2	Immunoglobulin G (IgG)IBA 01/2019 - 12/2018
2	Transcription Factor CHOPIBA 11/2018 - 09/2013
2	Phosphates (Orthophosphate)IBA 01/2018 - 11/2016
2	CreatinineIBA 01/2018 - 08/2014
2	6-ethyl-24-norcholane-3,7,23-triol-23 sulfateIBA 01/2018 - 01/2014
2	Protein Kinases (Protein Kinase)IBA 01/2017 - 09/2013
2	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 01/2017
2	FructoseIBA 10/2016 - 08/2014
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2014 - 06/2010
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2013 - 01/2010
2	Liver X ReceptorsIBA 01/2013 - 09/2006
2	ApolipoproteinsIBA 06/2010 - 12/2006
2	LipopolysaccharidesIBA 01/2010 - 02/2008
2	ElementsIBA 02/2009 - 05/2005
2	SterolsIBA 02/2009 - 05/2005
2	Sterol Regulatory Element Binding Protein 1IBA 07/2006 - 05/2005
2	Carvedilol (Coreg)FDA LinkGeneric 12/2004 - 12/2003
2	Phospholipids (Phosphatides)FDA LinkGeneric 03/2004 - 02/2003
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2024
1	Urate Oxidase (Uricase)IBA 04/2024
1	Uric Acid (Urate)IBA 04/2024
1	Xanthine OxidaseIBA 04/2024
1	Oxypurinol (Oxipurinol)IBA 04/2024
1	AllantoinIBA 04/2024
1	InflammasomesIBA 04/2024
1	Oxonic AcidIBA 04/2024
1	CollagenIBA 01/2024

Therapy/Procedure

8	Therapeutics 04/2024 - 05/2012
2	Drug Therapy (Chemotherapy) 01/2018 - 12/2013
1	Intranasal Administration 01/2024